Biomarker and Subgroup Insights on Novel CIDP Therapy Riliprubart: Luis Querol, MD, PhD
Eplontersen Slows Disability Progression and Deterioration of Gait Speed in ATTRv Polyneuropathy
UK Analysis Shows Low Transthyretin Levels Linked to Increased Risk of Multiple Diseases
Investigational Imlifidase Shows Rapid and Sustained Improvement of Guillain-Barré Syndrome Symptoms